MULTIPLEX (+/-) STRANDED ARRAYS AND ASSAYS FOR DETECTING CHROMOSOMAL ABNORMALITIES ASSOCIATED WITH CANCER AND OTHER DISEASES

• US 20110086772A1
• Filed: 09/27/2010
• Published: 04/14/2011
• Est. Priority Date: 09/25/2009
• Status: Abandoned Application

• Current Assignee: Signature Genomic Laboratories LLC (Revvity, Inc.)
• Original Assignee: Signature Genomics Laboratories, LLC (Revvity, Inc.)
• Inventors: Tebbs, Brice, Schultz, Roger, Ballif, Blake, McDaniel, Lisa, Shaffer, Lisa, Bejjani, Bassem
• Application Number:
  US12/891,623
• Publication Number:
  US 20110086772A1
• Time in Patent Office: Days
• US Class Current: 506/9
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 2539/101 Subtraction analysis
• CPC Class Codes: C12Q 2565/513 characterised by the pattern of the arrayed oligonucleotides
• CPC Class Codes: C12Q 2565/519 characterised by the capture moiety being a single stranded oligonucleotide

Abstract

Multiplex (+/−) stranded analyses, such as array comparative genomic hybridization (aCGH), are provided for detecting chromosomal rearrangements associated with cancer and other diseases. For example, an illustrative multiplex array for CGH includes discrete plus (+) strand and minus (−) strand DNA probes, complementary to each other but separable on the CGH array. The minus (−) strand DNA probes recover diagnostic information lost to conventional microarrays, since many genes transcribe from the minus (−) strand. In an illustrative system, patient and control DNA samples are prepared for CGH by amplification and labeling using comprehensive primers that generate both plus (+) strands and minus (−) strands of DNA in the samples. The breakpoints of a translocated chromosome may be detected on a multiplex microarray by DNA probes of one polarity, while DNA copy number changes associated with the translocation region may be detected by corresponding DNA probes of the complementary polarity. Related methods for identifying translocation partner genes are also provided.

Claims

1. A method for detecting chromosomal rearrangements, comprising receiving a DNA sample and analyzing the DNA sample via comparative genomic hybridization for chromosomal rearrangements using an array of plus (+)-stranded DNA probes and minus (−

)-stranded DNA probes.

2. The method of claim 1, wherein at least some of the plus (+)-stranded DNA probes each have a corresponding minus (−

)-stranded DNA probe, wherein a plus (+)-stranded DNA probe and a corresponding minus (−

)-stranded DNA probe are complementary reciprocals of each other.

3. The method of claim 2, wherein a plus (+)-stranded DNA probe and a corresponding minus (−

)-stranded DNA probe provide complementary hybridization targets for analyzing a chromosomal rearrangement of at least part of a DNA sequence of a genomic locus.

4. The method of claim 1, further comprising visualizing hybridization results at the plus (+)-stranded DNA probes and the minus (−

)-stranded DNA probes as separate analyses defining one or more chromosomal rearrangements at genomic loci.

5. The method of claim 1, wherein analyzing the DNA sample includes performing an array analysis using an array that includes discrete plus (+)-stranded DNA probes and discrete minus (−

)-stranded DNA probes as separate hybridization targets.

6. A method for detecting chromosomal rearrangements, comprising:

receiving a subject DNA sample;

receiving a control DNA sample;

adding primers to the subject DNA sample and the control DNA sample for amplifying chromosomal regions;

amplifying the subject DNA sample to produce plus (+) strands of patient DNA and minus (−

) strands of subject DNA representing the chromosomal regions, the (+) strands of subject DNA and the minus (−

) strands of subject DNA within a subject DNA product that includes amplified subject DNA and unamplified subject DNA;

labeling the plus (+) strands and the minus (−

) strands of the subject DNA product with at least a first label to provide a labeled subject DNA product;

amplifying the control DNA sample to produce plus (+) strands of control DNA and minus (−

) strands of control DNA representing the chromosomal regions, the (+) strands of control DNA and the minus (−

) strands of control DNA within a control DNA product that includes amplified control DNA and unamplified control DNA; and

labeling the plus (+) strands and the minus (−

) strands of the control DNA product with at least a second label to provide a labeled control DNA product.

7. The method of claim 6, further comprising attaching plus (+) strand DNA hybridization targets and minus (−

) strand DNA hybridization targets to a single comparative genomic hybridization (CGH) array for simultaneously detecting one or more of;

a balanced translocation in the chromosomal regions of diagnostic significance;

a translocation partner gene associated with a detected balanced translocation;

a copy number gain; and

a copy number loss.

8. The method of claim 7, further comprising attaching microRNAs to the CGH array as hybridization targets.

9. The method of claim 7, further comprising analyzing the subject DNA sample, wherein said analyzing comprises hybridizing the labeled subject DNA product and the labeled control DNA product to the CGH microarray, the CGH microarray including the plurality of plus (+) strand DNA hybridization targets and the minus (−

) strand DNA hybridization targets corresponding to the plurality of genomic loci.

10. The method of claim 9, further comprising detecting a DNA copy number variation at a genomic locus via at least one of the complementary reciprocal DNA hybridization targets.

11. The method of claim 9, further comprising detecting a disease condition via one of the plus (+) strand DNA hybridization targets or the minus (−

) strand DNA hybridization targets.

12. The method of claim 9, further comprising detecting a balanced chromosomal translocation at a genomic locus of the subject DNA sample via one of the plus (+) strand DNA hybridization targets or one of the minus (−

) strand DNA hybridization targets.

13. The method of claim 12, further comprising identifying a translocation partner gene associated with the balanced chromosomal translocation.

14. The method of claim 12, wherein detecting a balanced chromosomal translocation at a genomic locus in the subject DNA sample includes detecting a hybridization pattern on the microarray, the pattern indicating one or more of:

a decline in a subject DNA fluorescence signal following or adjacent to a translocation breakpoint in the DNA sequence representing the genomic locus;

a corresponding increase in a subject DNA fluorescence signal at one or more DNA hybridization targets representing the translocation partner gene on the array; and

an absence of corresponding declines and increases in the corresponding control DNA fluorescence signals.

15. The method of claim 6, further comprising selecting first primers to provide plus (+) strand DNA products and minus (−

) strand DNA products that enable detection of a genomic translocation in a gene selected from the group consisting of ABL1, ALK, BCR, CBFB, ETV6, IGH, IGK, IGL, MLL, PDGFB, PDGFRB, PICALM, RARA, RBM15, RPN1, RUNX1, TCF3, TLX3, TRA/D, and TRB.

16. The method of claim 6, further comprising selecting second primers to provide plus (+) strand DNA products and minus (−

) strand DNA products that enable detection of translocation partner genes.

17. The method of claim 6, further comprising labeling the subject DNA sample and the control DNA sample non-enzymatically to prevent making additional plus (+) and/or minus (−

) strand copies of DNA during the labeling.

18. The method of claim 6, further comprising labeling the amplified subject DNA product and the amplified control DNA product with separate labels, wherein each separate label can be differentiated.

19. A method for detecting chromosomal rearrangements, comprising:

obtaining a DNA sample;

amplifying the DNA sample to produce plus (+)-stranded DNA and minus (−

)-stranded DNA representing chromosomal regions of diagnostic interest within a DNA product that includes amplified DNA and unamplified DNA;

labeling the plus (+)-stranded DNA and the minus (−

)-stranded DNA with at least a first label to provide a labeled DNA product;

hybridizing the labeled DNA product to an array that includes plus (+)-stranded DNA targets and complementary minus (−

)-stranded DNA targets; and

analyzing the microarray to detect a chromosomal translocation in the labeled DNA product.

20. The method of claim 19, further comprising visualizing hybridization results at the plus (+)-stranded DNA probes and the minus (−

)-stranded DNA probes as separate analyses, wherein some chromosomal translocations are detected by the (+)-stranded DNA probes while other chromosomal translocations are detected by the (−

)-stranded DNA probes.

21. An array for the detection of chromosomal abnormalities comprising plus (+)-stranded DNA probes and minus (−

)-stranded DNA probes.

22. The array of claim 21, wherein at least some of the plus (+)-stranded DNA probes each have a corresponding minus (−

)-stranded DNA probe, wherein a plus (+)-stranded DNA probe and a corresponding minus (−

)-stranded DNA probe are complementary reciprocals of each other.

23. The array of claim 21, wherein substantially all of the plus (+)-stranded DNA probes each have a corresponding minus (−

)-stranded DNA probe, wherein a plus (+)-stranded DNA probe and a corresponding minus (−

)-stranded DNA probe are complementary reciprocals of each other.

24. The array of claim 21, wherein the array includes probes specific for a gene selected from the group consisting of ABL1, ALK, BCR, CBFB, ETV6, IGH, IGK, IGL, MLL, PDGFB, PDGFRB, PICALM, RARA, RBM15, RPN1, RUNX1, TCF3, TLX3, TRA/D, and TRB.

25. The array of claim 21, wherein the array includes probes specific for at least 10 of the following genes:

ABL1, ALK, BCR, CBFB, ETV6, IGH, IGK, IGL, MLL, PDGFB, PDGFRB, PICALM, RARA, RBM15, RPN1, RUNX1, TCF3, TLX3, TRA/D, and TRB.